Carter, A. W. (2014). FDA-Approved Biosimilar Insulin: Good Enough for Critical Care, Adulterated, or Counterfeit? How Can We Tell? J Diabetes Sci Technol.
Chicago Stili AlıntıCarter, Alan W. "FDA-Approved Biosimilar Insulin: Good Enough for Critical Care, Adulterated, or Counterfeit? How Can We Tell?" J Diabetes Sci Technol 2014.
MLA AlıntıCarter, Alan W. "FDA-Approved Biosimilar Insulin: Good Enough for Critical Care, Adulterated, or Counterfeit? How Can We Tell?" J Diabetes Sci Technol 2014.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..